Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer

Mutlu, HASAN; Musri, FATMA; Artac, Mehmet; KARGI, Aysegul; OZDOGAN, Mustafa; BOZCUK, Hakan

doi:10.4103/0973-1482.154008

Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer

Mutlu H., Musri F., Artac M., KARGI A., OZDOGAN M., BOZCUK H.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.11, no.2, pp.287-290, 2015 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 11 Issue: 2
Publication Date: 2015
Doi Number: 10.4103/0973-1482.154008
Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.287-290
Keywords: Breast cancer, heavily treated, metronomic, survival, PHASE-III TRIAL, CYCLOPHOSPHAMIDE, COMBINATION, CAPECITABINE, BENEFIT, ANTHRACYCLINE, BEVACIZUMAB, ETOPOSIDE, SURVIVAL, DOXORUBICIN
Akdeniz University Affiliated: Yes

Abstract

Background: We aimed to assess the efficacy of a metronomic regimen with cyclophosphamide and etoposide in heavily treated patients with metastatic breast cancer (MBC).